573 related articles for article (PubMed ID: 30890553)
1. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
[TBL] [Abstract][Full Text] [Related]
3. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway.
Chen J; Xu Q; Liu D; Li X; Guo M; Chen X; Liao J; Lei R; Li W; Huang H; Saw PE; Song E; Yan X; Nie Y
Cancer Commun (Lond); 2023 Nov; 43(11):1244-1266. PubMed ID: 37856423
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
5. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
6. Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression.
Xu J; Shi Q; Lou J; Wang B; Wang W; Niu J; Guo L; Chen C; Yu Y; Huang Y; Guo W; Lan J; Zhu Y; Ren T; Tang X
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37185233
[TBL] [Abstract][Full Text] [Related]
7. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
8. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
[TBL] [Abstract][Full Text] [Related]
9. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
[TBL] [Abstract][Full Text] [Related]
10. CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
Casagrande N; Borghese C; Visser L; Mongiat M; Colombatti A; Aldinucci D
Haematologica; 2019 Mar; 104(3):564-575. PubMed ID: 30309853
[TBL] [Abstract][Full Text] [Related]
11. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
[TBL] [Abstract][Full Text] [Related]
12. Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme.
Kranjc MK; Novak M; Pestell RG; Lah TT
Radiol Oncol; 2019 Nov; 53(4):397-406. PubMed ID: 31747383
[TBL] [Abstract][Full Text] [Related]
13. CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer.
Ding H; Zhao L; Dai S; Li L; Wang F; Shan B
Biomed Pharmacother; 2016 Feb; 77():142-9. PubMed ID: 26796278
[TBL] [Abstract][Full Text] [Related]
14. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
[TBL] [Abstract][Full Text] [Related]
15. Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.
Gao LF; Zhong Y; Long T; Wang X; Zhu JX; Wang XY; Hu ZY; Li ZG
J Exp Clin Cancer Res; 2022 Mar; 41(1):81. PubMed ID: 35241150
[TBL] [Abstract][Full Text] [Related]
16. Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages.
An G; Wu F; Huang S; Feng L; Bai J; Gu S; Zhao X
Oncol Rep; 2019 Dec; 42(6):2499-2511. PubMed ID: 31578575
[TBL] [Abstract][Full Text] [Related]
17. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
Cha YJ; Koo JS
PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
[TBL] [Abstract][Full Text] [Related]
18. CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer.
Svensson S; Abrahamsson A; Rodriguez GV; Olsson AK; Jensen L; Cao Y; Dabrosin C
Clin Cancer Res; 2015 Aug; 21(16):3794-805. PubMed ID: 25901081
[TBL] [Abstract][Full Text] [Related]
19. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
